News
Stay up to date on the latest company news:
09 October 2024
²»Á¼Ñо¿Ëù Appoints Gerben Moolhuizen as Chief Executive Officer
18 March 2024
²»Á¼Ñо¿Ëù selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)
18 October 2022
²»Á¼Ñо¿Ëù Appoints Thomas Bogenrieder as Chief Medical Officer
12 August 2022
²»Á¼Ñо¿Ëù---arenaviruses take on cancer
14 October 2021
²»Á¼Ñо¿Ëù Completes Series A Extension Bringing Total Raised to EUR 43 Million
05 February 2020
²»Á¼Ñо¿Ëù Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts
15 October 2019
²»Á¼Ñо¿Ëù Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
Events
Want to get in touch with the ²»Á¼Ñо¿Ëù Team? Meet us at the following events:
February 26-27, 2025
Sachs Associates 18th Annual European Life Sciences CEO Forum
Location: Zurich, Switzerland
Presentation: Oral company presentation
Presenters: Gerben Moolhuizen, CEO
Date: February 26-27, 2025
March 12-14, 2025
SITC Spring Scientific
Location: San Diego, USA
Poster Presentation: Arenavirus immunotherapy induces favorable anti-tumor immune mechanisms improving checkpoint and cell therapies
Presenter: Ulrike Köhler, Senior Scientist
Date: March 12-14, 2025
May 12-14, 2025
22nd CIMT Annual Meeting
Location: Mainz, Germany
Poster Presentation
Presenter: Maria Hønholt Christensen; Research Scientist
Date: May 12-14, 2025
May 12-14, 2025
Bio€quity Europe
Location: Bruges, Belgium
Participant: Gerben Moolhuizen, CEO
Date: May 12-14, 2025
June 16-19, 2025
BIO International Convention
Location: Boston, USA
Participant: Gerben Moolhuizen, CEO
Date: June 16-19, 2025